Discover
Foundation Fighting Blindness
Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy

Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy
Update: 2025-09-30
Share
Description
Durable vision improvements were also observed out to 18 months for previously dosed adult patients in the trial.
Comments
In Channel